BioSpace News Archive

Drug Development

Engage Therapeutics Announces Phase 2b StATES Study of Staccato® Alprazolam for Seizure Cessation Meets Primary Endpoint

Engage Therapeutics, Inc. announced that its Phase 2b StATES study of Staccato® alprazolam met its primary endpoint which was proportion of responders achieving cessation of seizure activity within two minutes of treatment administration and no recurrence within two hours.

March 11, 2020
·
4 min read
Business

Gritstone Oncology Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights

Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today reported financial results for the fourth quarter and full year ended December 31, 2019 and reviewed business highlights

March 11, 2020
·
10 min read
Business

Welldoc Announces Collaboration with Dexcom to Enhance the Value of BlueStar® with the Dexcom G6® CGM System

Welldoc, announced today a collaboration with Dexcom, the global leader in continuous glucose monitoring (CGM) systems for people with diabetes.

March 11, 2020
·
3 min read
Genetown

Persivia Announces the Availability of the Latest Version of smartLab™ its Electronic Testing Orders and Results System for Public Health Departments to Support COVID-19 Novel Coronavirus Testing

Persivia, a provider of value-based care, population health, quality management, and public health solutions, today announced the general availability of the third generation of its smartLab™ module.

March 11, 2020
·
3 min read
Deals

Medicus IT Acquires Managed Service Provider Nexus Practice IT Services

Medicus IT (MIT), a leading healthcare-focused managed services provider (MSP) based in Alpharetta, Georgia, announced the acquisition of Nexus Practice IT Services (Nexus).

March 11, 2020
·
3 min read
Business

Babson Diagnostics Bolsters Board of Directors with Three Diagnostics Industry Experts

Babson Diagnostics (Babson), a transformative diagnostic blood testing company, announced today that it has expanded its board of directors to include diagnostics industry leaders David Stein (Director), Dennis Gilbert (Director), and Dave Hickey (Observer).

March 11, 2020
·
4 min read
Genetown

Multi-National PRESTO Study Presented by ENETS with Simultaneous Publication in Advances in Therapy

Ipsen Biopharmaceuticals, an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY) today announced the presentation of the Presto study by ENETS.

March 11, 2020
·
15 min read
BioCapital

Cocrystal Pharma Announces Closing of $6.8 Million Registered Direct Offering Priced At-the-Market

COCRYSTAL PHARMA, INC. announced registered direct offering with several institutional investors for 5,037,038 shares of its common stock at a purchase price of $1.35 per share, priced at-the-market under Nasdaq rules.

March 11, 2020
·
3 min read
Biosight Raises $19M in Series C Funding to Support Clinical Stage Oncology ProgramsProceeds support clinical advancement of BST-236, a proprietary anti-metabolite enabling high-dose chemotherapy with reduced systemic toxicity

Biosight Ltd . today announced the raising of a $19M Series C financing. The investment is led by Israel Biotech Fund (IBF) with participation by SBI JI Innovation Fund, Arkin Bio Ventures, and additional new and existing investors.

March 11, 2020
·
3 min read
Business

OyaGen, Inc. Announces a Compound in Development with Broad Antiviral Activity Against Coronaviruses, including SARS-CoV-2

OyaGen, Inc. announced today new unpublished results from collaborative research with the National Institute of Allergy and Infectious Diseases’ Integrated Research Facility at Fort Detrick, MD

March 11, 2020
·
2 min read